Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cardium Therapeutics and its operating unit InnerCool Therapies have announced that InnerCool has entered into an exclusive commercialization agreement with NGC Medical, an Italian distributor of medical products.
Subscribe to our email newsletter
According to Cardium Therapeutics, the agreement covers InnerCool’s CoolBlue, a nurse-friendly and cost-effective surface cooling temperature modulation system, which was launched in the US market during the fourth quarter 2007, as well as InnerCool’s Celsius Control endovascular system and next-generation, high-performance RapidBlue system.
InnerCool’s new CoolBlue surface temperature modulation system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a tool for use in less acute patients or in clinical settings best suited to prolonged temperature management, said Cardium Therapeutics.
Using NGC Medical’s marketing and sales force, sales of CoolBlue and RapidBlue consoles and disposables are expected to begin in Italy in the third quarter of 2008.